Abstract: A method for operating a data processing agent for processing data from an automated medical sample analyzer is presented. The method comprises receiving at least one automated analyzer status datum transmitted from at least one automated analyzers in a medical sample analysis system to the data processing agent, wherein the automated analyzer status data is generated by the at least one automated analyzer in response to an automated analyzer condition detected by an automated analyzer, receiving at least one annotation datum at the data processing agent, associating at least one automated analyzer status datum with at least one annotation datum using the processing agent to generate an automated analyzer system data record, and outputting the automated analyzer system data record from the data processing agent, wherein the automated analyzer system data record comprises at least one automated analyzer device status datum associated with at least one annotation datum.

Abstract: Application discovery from access patterns is disclosed. Access histories from multiple servers are collected and stored at a warehouse, which me part of a data protection system. A time series analysis is performed on the access history to identify consistency groups and applications from the perspective of devices and storage arrays. Data protection operations such as backup operations can then be performed on the basis of devices or storage in storage arrays or other arrangements that pertain to specific consistency groups or to specific applications.

Abstract: A system for automatically displaying virtual objects within a mixed reality environment is described. In some embodiments, a see-through head-mounted display device (HMD) identifies a real object (e.g., a person or book) within a field of view of the HMD, detects one or more interactions associated with real object, and automatically displays virtual objects associated with the real object if the one or more interactions involve touching or satisfy one or more social rules stored in a social rules database. The one or more social rules may be used to infer a particular social relationship by considering the distance to another person, the type of environment (e.g., at home or work), and particular physical interactions (e.g., handshakes or hugs). The virtual objects displayed on the HMD may depend on the particular social relationship inferred (e.g., a friend or acquaintance).

Abstract: A gas meter is configured for diagnostics using differential pressure (DP) measurements. The configurations include executable instructions to actively manage the DP sensor. These instructions active the DP sensor only during stable flow and, where applicable, for a defined test time period. This feature manages power consumption to maintain battery life with acceptable standards or regulations.

Abstract: Techniques are described that enable maintaining of session stickiness across authentication and authorization channels in an access management system, through the use an identifier for an access manager from a plurality of access managers. The access manager authenticates a user of a client device based on an authentication request. In response to response to successful authentication of the user, the access manager creates a session. The access manager also generates the identifier and causes the identifier to be stored for the session. The access manager can then receive a second request, which is sent to the access manager based on identifying the access manager using the stored identifier.

Abstract: The disclosed technology generally relates to electrical overstress protection devices, and more particularly to electrical overstress monitoring devices for detecting electrical overstress events in semiconductor devices. In one aspect, an electrical overstress monitor and/or protection device includes a two different conductive structures configured to electrically arc in response to an EOS event and a sensing circuit configured to detect a change in a physical property of the two conductive structures caused by the EOS event. The two conductive structures have facing surfaces that have different shapes.

Abstract: Methods, compositions, and kits for adjunctive therapy using 25-hydroxyvitamin D are disclosed. The 25-hydroxyvitamin D may be administered with an agent that increases the risk of hypocalcemia, such as cinacalcet or a salt thereof, and/or an anticancer agent. The adjunctive therapy is effective to treat and prevent iatrogenic hypocalcemia and/or secondary hyperparathyroidism, as well as delay cancer progression and the time to a post-treatment skeletal related event.

Abstract: Provided are polymer compositions made by a process comprising: (a) providing a first reactive composition containing: (i) a polymerization initiator that is capable, upon a first activation, of forming two or more free radical groups, at least one of which is further activatable by subsequent activation; (ii) one or more ethylenically unsaturated compounds; and (iii) a crosslinker; (b) subjecting the first reactive composition to a first activation step such that the first reactive composition polymerizes therein to form a crosslinked substrate network containing a covalently bound activatable free radical initiator, (c) combining the crosslinked substrate network with a second reactive composition containing one or more ethylenically unsaturated compounds; and (d) activating the covalently bound activatable free radical initiator of the crosslinked substrate network such that the second reactive composition polymerizes therein with the crosslinked substrate network to form a grafted polymeric network and a

Abstract: A protective apparatus for a distribution line conductor includes an elongate tube configured to be installed on the conductor and a plurality of annular members concentrically positioned on the tube and configured to rotate independently of each other. The tube has a longitudinal axis and defines a longitudinally extending chamber configured to receive the conductor. The tube has opposite first and second ends and a longitudinally extending opening from the first end to the second end that facilitates installation of the elongate tube on the conductor. Each annular member includes an outer surface and a plurality of circumferentially-spaced apart members extending outwardly from the outer surface. Each annular member includes a longitudinally extending slot that is configured to align with the longitudinally extending opening of the tube to facilitate installation of the elongate tube and the plurality of annular members as an assembly on the conductor.

Abstract: A method for processing data of an analytical instrument for analyzing biological samples is presented. The method comprises receiving instrument data from the analytical instrument at a data processing module communicatively connected with the analytical instrument, generating metadata from the received instrument data at the data processing module, applying a first encryption to the instrument data at the data processing module, applying a second encryption to the generated metadata at the data processing module, and transmitting the encrypted metadata and encrypted instrument data to a remote server. The remote server and the data processing module are communicatively connected. The method also comprises removing the second encryption from the metadata at the remote server and forwarding the instrument data encrypted by the first encryption from the remote server to a management system of the analytical instrument.

Abstract: A method for processing data of an analytical instrument for analyzing biological samples is presented. The method comprises receiving instrument data from the analytical instrument at a data processing module communicatively connected with the analytical instrument, generating metadata from the received instrument data at the data processing module, applying a first encryption to the instrument data at the data processing module, applying a second encryption to the generated metadata at the data processing module, and transmitting the encrypted metadata and encrypted instrument data to a remote server. The remote server and the data processing module are communicatively connected. The method also comprises removing the second encryption from the metadata at the remote server and forwarding the instrument data encrypted by the first encryption from the remote server to a management system of the analytical instrument.

Abstract: The invention relates to N-hydroxysulfonamide derivatives that donate nitroxyl (HNO) under physiological conditions and are useful in treating and/or preventing the onset and/or development of diseases or conditions that are responsive to nitroxyl therapy, including heart failure and ischemia/reperfusion injury. Novel N-hydroxysulfonamide derivatives release HNO at a controlled rate under physiological conditions, and the rate of HNO release is modulated by varying the nature and location of functional groups on the N-hydroxysulfonamide derivatives.

Abstract: Techniques to provide a micro-broadcast of an event are described. Video data streams of a live event at a venue may be captured in one or more wireless camera devices. The data streams may be sent to one of a network of wireless access points where they are relayed to a control center. A computer system in the control center may select one of the video data streams to be broadcast as a micro-broadcast. The selected video data stream may then be formatted for the micro-broadcast before a micro-broadcast transmitter broadcasts the formatted selected video data stream.

Abstract: The disclosed subject matter provides N-substituted hydroxylamine derivative compounds, pharmaceutical compositions and kits comprising such compounds, and methods of using such compounds or pharmaceutical compositions. In particular, the disclosed subject matter provides methods of using such compounds or pharmaceutical compositions for treating heart failure.

Abstract: The invention relates to N-hydroxysulfonamide derivatives that donate nitroxyl (HNO) under physiological conditions and are useful in treating and/or preventing the onset and/or development of diseases or conditions that are responsive to nitroxyl therapy, including heart failure and ischemia/reperfusion injury. Novel N-hydroxysulfonamide derivatives release HNO at a controlled rate under physiological conditions, and the rate of HNO release is modulated by varying the nature and location of functional groups on the N-hydroxysulfonamide derivatives.

Abstract: The disclosed subject matter provides N-substituted hydroxylamine derivative compounds, pharmaceutical compositions and kits comprising such compounds, and methods of using such compounds or pharmaceutical compositions. In particular, the disclosed subject matter provides methods of using such compounds or pharmaceutical compositions for treating heart failure.

Abstract: A mechanical seal assembly has rotational and stationary sealing members) and a drive unit, which is axially adjacent one of the sealing members. An energizing member urges the drive unit towards the sealing members. A retainer axially and radially retains one of the sealing members. The drive unit is in contact with one of the rotational and stationary members by way of contacting surfaces which are in the range of 1 and 20 light bands of flatness, inclusive.

Abstract: The disclosed subject matter provides N-hydroxylsulfonamide derivative compounds of formulae (I), (II) or (III) as drawn below, pharmaceutical compositions comprising such compounds, kits comprising such compounds, and methods of using such compounds or pharmaceutical compositions. In particular, the disclosed subject matter provides methods of using such compounds or pharmaceutical compositions for treating heart failure.

Abstract: The disclosed subject matter provides pyrazolone derivative compounds, pharmaceutical compositions comprising such compounds, kits comprising such compounds, and methods of using such compounds or pharmaceutical compositions. In particular, the disclosed subject matter provides methods of using such compounds or pharmaceutical compositions for treating heart failure.

Abstract: The present disclosure provides nitroxyl donating pharmaceutical compositions comprising N-substituted hydroxylamine derivatives. The compositions are highly efficacious in treating cardiovascular diseases (e.g., heart failure), have a suitable toxicological profile, and are sufficiently stable for intravenous or oral administration.